Arca Biopharma reported $3.5M in Current Liabilities for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US $ 12618M 268M
Arca Biopharma ABIO:US $ 3.5M 0.62M
Biogen BIIB:US $ 5018M 1071.4M
Brainstorm Cell Therapeutics BCLI:US $ 7.85M 0.47M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Capricor Therapeutics CAPR:US $ 19.55M 5.22M
Cytokinetics CYTK:US $ 66.84M 0M
Cytrx CYTR:US 3.1M 633.56K
Daiichi Sankyo 4568:JP Y 406816M 11548M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 37835M 13557M
Laboratory Of America LH:US $ 2642.9M 1.4M
Myriad Genetics MYGN:US $ 119.7M 46.3M
Otsuka Holdings 4578:JP Y 529371M 55204M
United Therapeutics UTHR:US $ 331.5M 38.9M